Thomas Struengmann & family
$11.5B
Born
Feb 16, 1950
Age
76
Source of Wealth
Pharmaceuticals
Residence
Tegernsee,
Citizenship
Germany
Marital Status
Married
Children
4
Education
Master of Business Administration, University of Augsburg; Master of Business Administration, University of Augsburg
- Thomas Struengmann and twin brother Andreas were early backers of German firm BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.
- The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.
- The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.
- In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.
- After obtaining a business degree from the University of Augsburg, Thomas worked as a marketing manager for Schering-Plough.
- Like his brother, an identical twin, he is said to be an accomplished golfer and likes to ski. He reportedly collects modern art and Swiss watches.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|